“The Beauty-Obsessed Scientist” Dr. Erin Tjam, former Director of Research at St. Mary’s General Hospital, and adjunct…
Category: Primers
$412.5 million! Mabwell Announces Exclusive Licensing Agreement with DISC MEDICINE, INC. for Innovative Drug Candidates of Hematologic Diseases
Mabwell (688062.SH), an innovative biopharmaceutical company with the layout of whole industry chain, announced its wholly-owned…
BriSTAR Immunotech To Present its Novel Cell Therapy for Acute Myeloid Leukemia at the AACR Special Conference on AML and MDS
BriSTAR Immunotech, a clinical-stage cell therapy company, announced today it will showcase its T-cell receptors (TCR)…
A Healthy Winter Action: Second Batch of 19,600 Bottles of Azvudine Delivered to 24 Counties
On January 16, the second stage of “A Healthy Winter Action” initiated by Fosun Foundation in conjunction…
LiveCare Corp Launches “Clinii” AI-Enabled Real-Time Interpretations of Care Team Conversations to Improve Care, Clinician Productivity and Billing Accuracy
LiveCare Corp, a leading provider of virtual practice management tools for primary and specialty care providers,…
Presentation to J.P. Morgan Healthcare Conference and Q4 2022 Illuccix Revenue Update
Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today advises it is presenting at the 41st Annual J.P.…
BioArctic’s partner Eisai submits supplemental Biologics License Application to FDA for traditional approval of LEQEMBI™ (lecanemab-irmb) for the treatment of Alzheimer’s disease
BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today they have submitted a supplemental…
Neurocrine Biosciences Announces U.S. FDA Accepts Supplemental New Drug Application for Valbenazine as a Treatment for Chorea Associated with Huntington Disease
Neurocrine Biosciences, Inc. (Nasdaq: NBIX), a leading neuroscience-focused biopharmaceutical company, today announced that the U.S. Food and Drug…
ATI Physical Therapy Names Healthcare Partnerships Leader Scott Gregerson as Chief Growth Officer
ATI Physical Therapy, Inc. (“ATI” or the “Company”) (NYSE: ATIP), the largest single-branded outpatient physical therapy provider in the United…
Northwest Tribes Celebrate Historic Congressional Funding Provision for Indian Health Service
Today, Congress passed the $1.7 trillion fiscal 2023 spending package, which included $5.1 billion in advance appropriations for the Indian…